$CSR

Centerspace (CSR) Q2 2026 Earnings Call Transcript

Centerspace (CSR) reported Q2 2026 Core FFO of $1.27 per diluted share, down 0.8% from $1.28 a year earlier, and same-store NOI up 0.3%. The company sold or contracted 14 communities in 2026 for about $320 million, exited Rapid City and is exiting Bismarck. Full-year Core FFO guidance was cut to $4.58 to $4.68. Liquidity was $242.6 million.

Original reporting
Published Aug 11, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Centerspace (CSR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CSRNeutralMed
01

Why it matters

The company lowered full-year Core FFO guidance and updated same-store NOI expectations to flat to down 1%, citing disposition timing and Denver softness from new supply absorption. It also highlighted improving leverage toward the mid-6x range and flagged a potential $50m to $60m special distribution in Q4.

02

Market read

Traders can update valuation assumptions around 2026 earnings power, disposition-driven FFO optics, and balance-sheet risk, with an explicit potential REIT distribution catalyst.

03

What to watch

Special distribution size and timing depend on taxable income from sales, and investors may underweight how the pending Bismarck disposition and net debt trajectory could change perceived risk.

Relevance 8/10Novelty 7/10Timing: ahead of next earnings/positioning for 2026 guidance and disposition-driven leverage path

Background

Centerspace’s Q2 2026 call centers on portfolio repositioning, exiting tertiary markets, and using disposition proceeds to reduce leverage while maintaining REIT status.

Company-level read

Ticker impact

$CSRNeutralMedium confidence
Context

Centerspace cut full-year Core FFO guidance to $4.58 to $4.68 and expects same-store NOI flat to down 1% after high disposition timing.

Expected impact

Near-term volatility likely as investors reprice earnings power versus balance-sheet improvement and distribution risk.

Evidence & confidence

The call provides specific, decision-relevant updates: lowered Core FFO range, updated same-store NOI/revenue outlook, liquidity and net debt to EBITDA trajectory, and a $50m to $60m potential special distribution.

Market effects

Reinforces that REIT earnings can be pressured by disposition timing and same-store NOI softness, while balance-sheet de-leveraging and distributions remain key investor focus.

Denver demand/supply imbalance is explicitly cited as the driver of negative same-store NOI, while Minneapolis is described as past its inflection point.

Limited direct global spillover; primarily a US multifamily/REIT earnings and capital-markets read-through.

Counterpoint

The guidance downgrade may be largely mechanical from excluding sold/held-for-sale assets, while operating fundamentals in core markets (notably Minneapolis) look steadier than the headline implies.

Key entities

  • Centerspace

    REIT reporting Q2 2026 results and revising 2026 guidance amid active community dispositions and regional performance divergence.

  • Anne Olson

    CEO who discussed Denver softness and Minneapolis stabilization after supply absorption.

  • Bhairav Patel

    CFO who quantified updated same-store NOI growth expectations and leverage/distribution implications.

Related articles

$CSRMed

CENTERSPACE (CSR): Completion of Acquisition or Disposition of Assets

CENTERSPACE (CSR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 dispositionproformafinanci.htm EX-99.1 Document Exhibit 99.1 CENTERSPACE AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The following pro forma condensed consolidated financial statements of Centerspace, collectively with its subsidiari

$CSRMedAI 8/10

Centerspace Reports Second Quarter 2026 Financial & Operating Results and Updates Financial Outlook Due to Disposition Activity

Centerspace (NYSE: CSR) reported Q2 2026 results for the three and six months ended June 30. Revenue fell to $65.8 million from $68.5 million, with net loss of $0.07 per diluted share. Core FFO per share was $1.27. The company disposed of Denver, Rapid City, and Minneapolis communities and updated 2026 outlook, expecting $315.0 million to $320.0 million in disposition proceeds.

$CSRMed

CENTERSPACE (CSR): Results of Operations and Financial Condition

CENTERSPACE (CSR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 centerspace063026exhibit991.htm EX-99.1 Document Exhibit 99.1 Earnings Release Centerspace Reports Second Quarter 2026 Financial & Operating Results and Updates Financial Outlook Due to Disposition Activity MINNEAPOLIS, MN, August 3, 2026 – Centerspace (NYSE: CSR) (the

$CRMDMed

CorMedix Q2 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported Q2 revenue rising to $39.7M from $39.7M a year earlier, with 2026 including $66.1M DefenCath sales and $35.8M from the Melinta portfolio. Net income was $26.0M ($0.33 basic). It reaffirmed 2026 revenue guidance of $325M-$345M and raised adjusted EBITDA to $125M-$140M. REZZAYO supplemental NDA is planned for Q3 2026, with FDA action expected H1 2027.

$CLXMed

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?

The article says The Clorox Company (CLX) shares have lagged the S&P 500 over 52 weeks, down 13.7% versus SPX up 20.6%. After Q4 2026 results on Aug. 3, CLX rose 6.5% on $1.95B sales and adjusted EPS $1.66, plus FY2027 net sales growth guidance of 13%-14%. Analysts: consensus Hold, JPMorgan raised PT to $95; stock trades above the mean $96.94, with a Street-high $117.

$CDNSMed

CDNS Falls 12.9% in the Past Month. Is the Sell-Off an Opportunity?

Cadence Design Systems (CDNS) shares fell 12.9% over the past month despite Q2 results. According to the company, Q2 revenue rose 24.2% to $1.584B and non-GAAP EPS rose 27.9% to $2.11. The company raised 2026 guidance to $6.26-$6.34B revenue and $8.05-$8.15 EPS, with backlog at a record $8.1B. Valuation remains at 36.3x forward earnings.